- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06812819
Effect of Cryostimulation on Selected Motor Skills in Soccer Players
Study Overview
Status
Conditions
Detailed Description
Anthropometric measurements Using Tanita BC-418 MA analyzer, (Medizin & Service GmbH, Germany), measurement accuracy was ± 0.1 kg. The following parameters were analyzed: body mass index (BMI), total body water (TBW), fat mass (FM), and fat-free mass (FFM), and basal metabolism (BMR), Table 1. All measurements were taken fasting at 8:00 a.m. on the first and fifth day of the study in both groups of subjects. The device was calibrated before each testing session according to the manufacturer's guidelines.
Fitness tests Measurements of step frequency and maximal power [W/kg] of the lower limbs were performed using the OptoGait optical system (MicroGate Timing and Sport, BONZAMO, Italy). The measurement system consisted of two panels used to detect spatial parameters for gait, jumping, and reaction time. Measurement strips were placed in parallel on the ground at a distance of 1.5 meters from each other. The test consisted of 3 parts: tapping (step frequency), maximal jumping up without upper limb sweep, and maximal jump up with upper limb assisted sweep (analysis of lower limb maximal power and jump height). Test subjects were positioned between the slats in the starting position, and performed 3 test trials, each trial began and ended with an audible signal, and the time of a single trial was 10 seconds. Analysis of the components of lower limb maximal power and step frequency was performed in the PBC and CON groups on the first and last days of the study.
Cryostimulation (PBC) PBC protocol involved the participant being in a JUKA cryosauna (model 0104-1), for 3 minutes at - 140 ° C± - 20 ° C with the lid at shoulder height and the head over the chamber. The cryosauna was cooled with liquid nitrogen, and the temperature was monitored by a computer. Participants entered the cabin wearing clogs, wool socks, shorts, gloves, caps, and disposable PP non-woven masks to protect against inhalation of nitrogen fumes. The temperature inside the cryosauna was recorded at 30-second intervals using a sensor placed on the bottom of the cabin. The temperature of the room where the cryosauna was located was 21.0 ± 0.9° C, and the humidity of the air during the treatment was 35 ± 2, 0 % monitored with a QUIGG type LE 2014.14 moisture absorber. All participants received instructions on proper breathing and cryosauna behavior before the PBC procedure. They received information on risks, complications, and indications for immediate discontinuation of the therapy. Athletes signed an informed consent for the experiment. During the PBC, they remained in constant visual and auditory contact with the therapy supervisor. A cryostimulation session was performed every day from 8:00-9:00 am, for 5 days. During one PBC treatment, the athletes spent 3 minutes at -140° C ± 20° C. Each entry into the cryosauna was preceded by a measurement of saturation temperature and blood pressure. These measurements were taken again each day immediately after exiting the cryosauna. After completing the cryotherapy procedure, the athletes were subjected to a 15-minute warm-up according to a set schedule.
Study Type
Contacts and Locations
Study Locations
-
-
Lubuskie
-
Gorzow Wielkopolski, Lubuskie, Poland, 66-400
- Department of Physiotherapy, Poznań University of Physical Education, Faculty of Sport Sciences In Gorzów Wielkopolski; Poland
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- TraAge: 18-35 years,
- Training: at least three years,
- regular training
- Health status: no musculoskeletal injuries,
- Medical certificate from a certified sports physician indicating readiness to participate in intensive training and cryostimulation treatments.
- Lifestyle restrictions:
agreement to refrain from additional regenerative therapies, cosmetic treatments, alcohol, stimulants and dietary supplements during the study.
Inclusion Criteria:
- TraAge: 18-35 years,
- Training: at least three years, regular training
- Health status: no musculoskeletal injuries,
- Medical certificate from a certified sports physician indicating readiness to participate in intensive training and cryostimulation treatments.
- Lifestyle restrictions: restrictions on additional regenerative therapies, cosmetic procedures, alcohol, stimulants and dietary supplements during the study.
Exclusion criteria:
- Age: under 18 or over 35 years of age,
- Training: less than three years of regular professional soccer training or playing.
- Health conditions: acute or chronic injuries, cardiovascular diseases, respiratory diseases or conditions that contraindicate cryostimulation,
- Failure to follow: planned training, testing or cryostimulation protocols; failure to follow lifestyle restrictions as outlined in the study guidelines,
- Contraindications to cryostimulation: sensitivity or adverse reactions to cold exposure.
Study Plan
How is the study designed?
Collaborators and Investigators
Investigators
- Principal Investigator: Izabela Różycka, mgr, Department of Physiotherapy, Poznań University of Physical Education, Faculty of Sport Sciences In Gorzów Wielkopolski; Poland
Study record dates
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 12622001541796, ANZCTR
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Particularly Partial-body Cryostimulation
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedEpilepsy | Epilepsy, Generalized | Seizures | Epilepsies, Partial
-
Medical University of ViennaNot yet recruitingBreast Feeding | Mental Health | Lactation | Maternal Behavior | Neonatal Jaundice | Patient Satisfaction and Experience With Integrative Therapies | Breast Feeding of Healthy Full Term Infants | Breast Feeding, Exclusive | Infant, Newborn | Body Weight Decreased | Postnatal Care | Lactation; Insufficient, Partial and other conditionsAustria
-
Regeneron PharmaceuticalsActive, not recruiting
-
University of MinnesotaWithdrawnMild Cognitive Impairment (MCI) | Amyotrophic Lateral Sclerosis (ALS) | Dementia With Lewy Bodies (DLB) | Alzheimer Disease (AD) | Frontotemporal Lobar Degeneration (FTLD) | Parkinsons Disease With Dementia (PDD) | Transient Epileptic Amnesia (TEA) | Temporal Lobe Epilepsy (TLE) | Spinocerebellar Ataxias... and other conditionsUnited States